The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Eric Groce
- Vol. 104, Iss: 4, pp 32-32
Reads0
Chats0
TLDR
Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.Abstract:
Recent years have seen a rapid rise in the medical and recreational use of cannabis: a broad term that can be used to describe the various products and chemical compounds (e.g., marijuana, cannabinoids) derived from different species of the cannabis plant. Despite increased cannabis use and a changing state-level policy landscape, conclusive evidence regarding the shortand long-term health effects—both harms and benefits—of cannabis use remains elusive.read more
Citations
More filters
Journal ArticleDOI
Cannabis and psychosis: what do we know and what should we do?
Marco Colizzi,Robin M. Murray +1 more
TL;DR: It is now incontrovertible that heavy use of cannabis increases the risk of psychosis and there is a dose–response relationship and high potency preparations and synthetic cannabinoids carry the greatest risk.
Journal ArticleDOI
Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
TL;DR: MC/R was associated with residing in a state in which RC is legal, being female, using MC for pain or mental health conditions, vaping MC concentrates, holding positive expectancies for combustible MC, and seeking out MC products with high THC concentrations.
Journal ArticleDOI
The impact of cannabis access laws on opioid prescribing
TL;DR: Analyzing a dataset of over 1.5 billion individual opioid prescriptions between 2011 and 2018, it is found that recreational and medical cannabis access laws reduce the number of morphine milligram equivalents prescribed each year by 11.8 and 4.2 percent.
Journal ArticleDOI
A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain.
TL;DR: Cumulative evidence from clinical trials and an exploratory analysis of the German Pain e-Registry suggests that add-on THC:CBD oromucosal spray (nabiximols) may have a role in managing chronic neuropathic pain, although further precise clinical trials are required to draw definitive conclusions.
Journal ArticleDOI
Marijuana Promotion Online: an Investigation of Dispensary Practices.
Patricia A. Cavazos-Rehg,Melissa J. Krauss,Elizabeth S. Cahn,Kiriam Escobar Lee,Erin G. Ferguson,Biva Rajbhandari,Shaina J. Sowles,Glennon M. Floyd,Carla J. Berg,Laura J. Bierut +9 more
TL;DR: The findings indicate that marijuana dispensary websites are easily accessible to youth, and only a small amount of the websites advised consumers about possible side effects or contraindications, which suggests the need for surveillance of marijuana commercialization and online advertising.
References
More filters
Journal ArticleDOI
Diagnostic and Statistical Manual of Mental Disorders
Vijay A. Mittal,Elaine F. Walker +1 more
TL;DR: An issue concerning the criteria for tic disorders is highlighted, and how this might affect classification of dyskinesias in psychotic spectrum disorders.
Journal ArticleDOI
Systematic Review: Process of Forming Academic Service Partnerships to Reform Clinical Education
TL;DR: This study’s findings can provide practical guidelines to steer partnership programs within the academic and clinical bodies, with the aim of providing a collaborative partnership approach to clinical education.
Journal ArticleDOI
The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials
Julian P T Higgins,Douglas G. Altman,Peter C Gøtzsche,Peter Jüni,David Moher,Andrew D Oxman,Jelena Savović,Kenneth F. Schulz,Laura Weeks,Jonathan A C Sterne +9 more
TL;DR: The Cochrane Collaboration’s tool for assessing risk of bias aims to make the process clearer and more accurate.
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
TL;DR: The Newcastle-Ottawa Scale (NOS) as discussed by the authors was developed to assess the quality of nonrandomised studies with its design, content and ease of use directed to the task of incorporating the quality assessments in the interpretation of meta-analytic results.
Journal ArticleDOI
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa Hm Moore,Stanley Zammit,Stanley Zammit,Anne Lingford-Hughes,Thomas R. E. Barnes,Peter B. Jones,Margaret Burke,Glyn Lewis +7 more
TL;DR: There is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life, although evidence for affective outcomes is less strong.